Cross-talk between heart and kidney - Mechanisms and management of the cardiorenal syndrome from a nephrologists view;"Cross-talk" zwischen herz und niere - Das kardiorenale syndrom und seine therapie aus der sicht des nephrologen

Therapeutische Umschau

Volumn 66, Issue 11, 2009, Pages 741-746

  Farese, Stefan ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

NATRIURETIC FACTOR;

ADRENERGIC SYSTEM; CARDIORENAL SYNDROME; COMORBIDITY; HEART FAILURE; HUMAN; HYPERVOLEMIA; KIDNEY DYSFUNCTION; MORTALITY; QUALITY OF LIFE; RENAL REPLACEMENT THERAPY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SODIUM RETENTION; VASOPRESSIN RELEASE; WATER RETENTION;

COMORBIDITY; HEART FAILURE; HUMANS; KIDNEY FAILURE; RENAL DIALYSIS; RENAL REPLACEMENT THERAPY;

EID: 70350662896     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.66.11.741     Document Type: Review

References (26)

1. Silverberg D, Wexler D, Blum M, Schwartz D, Iaina A. The association between congestive heart failure and chronic renal disease. Curr Opin Nephrol Hypertens. 2004; 13: 163-170. (Pubitemid 38373138)
2. Schreiber BD. Congestive heart failure in patients with chronic kidney disease and on dialysis. Am J Med Sci. 2003; 325: 179-193. (Pubitemid 36442680)
3. Liu PP. Cardiorenal syndrome in heart failure: a cardiologist's perspective. Can J Cardiol. 2008;24 Suppl B: 25B-9B.
4. Schrier RW. Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor? J Am Coll Cardiol. 2006; 47: 1-8.
5. Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol. 2008; 52: 1527-1539.
6. Liang KV, Williams AW, Greene EL, Redfield MM. Acute decompensated heart failure and the cardiorenal syndrome. Crit Care Med. 2008; 36: S75-88.
7. Gohil K, Schock BC, Chakraborty AA, Terasawa Y, Raber J, Farese RV, Jr., et al. Gene expression profile of oxidant stress and neurodegeneration in transgenic mice deficient in alpha-tocopherol transfer protein. Free Radic Biol Med. 2003; 35: 1343-1354. (Pubitemid 37452460)
8. Yoshida H, Yashiro M, Liang P, Muso E, Takeuchi E, Shimada T, et al. Mesangiolytic glomerulopathy in severe congestive heart failure. Kidney Int. 1998; 53: 880-891. (Pubitemid 28155660)
9. Pasch A, Schaffner T, Huynh-Do U, Frey BM, Frey FJ, Farese S. Sodium thiosulfate prevents vascular calcifications in uremic rats. Kidney Int. 2008; 74: 1444-1453.
10. Frey FJ, Mordasini RC, Schlumpf E, Marone C, Montandon A, Flury W, et al. [Serum lipids in diminished kidney function, during hemodialysis and after kidney transplantation]. Schweiz Med Wochenschr. 1977; 107: 1248-1253.
11. Amann K, Ritz C, Adamczak M, Ritz E. Why is coronary heart disease of uraemic patients so frequent and so devastating? Nephrol Dial Transplant. 2003; 18: 631-640.
12. Patel UD, Hernandez AF, Liang L, Peterson ED, LaBresh KA, Yancy CW, et al. Quality of care and outcomes among patients with heart failure and chronic kidney disease: A Get With the Guidelines-Heart Failure Program study. Am Heart J. 2008; 156: 674-681.
13. Cice G, Ferrara L, D'Andrea A, D'Isa S, Di Benedetto A, Cittadini A, et al. Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial. J Am Coll Cardiol. 2003; 41: 1438-1444. (Pubitemid 36543357)
14. Laufs U, Custodis F, Bohm M. Who does not need a statin: too late in end-stage renal disease or heart failure? Heart. 2008; 94: 1138-1140.
15. Witham MD, Gillespie ND, Struthers AD. Hyperkalemia after the publication of RALES. N Engl J Med. 2004; 351: 2448-2450; author reply -50.
16. Khalifeh N, Vychytil A, Horl WH. The role of peritoneal dialysis in the management of treatment-resistant congestive heart failure: A European perspective. Kidney Int Suppl. 2006: S72-5.
17. Agrawal V, Ghosh AK, Barnes MA, McCullough PA. Perception of Indications for Nephrology Referral among Internal Medicine Residents: A National Online Survey. Clin J Am Soc Nephrol. 2008.
18. Cridlig J, Selton-Suty C, Alla F, Chodek A, Pruna A, Kessler M, et al. Cardiac impact of the arteriovenous fistula after kidney transplantation: a case-controlled, match-paired study. Transpl Int. 2008; 21: 948-954.
19. Bossola M, Tazza L, Vulpio C, Luciani G. Is regression of left ventricular hypertrophy in maintenance hemodialysis patients possible? Semin Dial. 2008; 21: 422-430.
20. Bouchard J, Khosla N, Mehta RL. Emerging therapies for extracorporeal support. Nephron Physiol. 2008; 109: p85-91.
21. Bart BA, Boyle A, Bank AJ, Anand I, Olivari MT, Kraemer M, et al. Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial. J Am Coll Cardiol. 2005; 46: 2043-2046. (Pubitemid 41713589)
22. Costanzo MR, Guglin ME, Saltzberg MT, Jessup ML, Bart BA, Teerlink JR, et al. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol. 2007; 49: 675-683. (Pubitemid 46205043)
23. Gotloib L, Fudin R, Yakubovich M, Vienken J. Peritoneal dialysis in refractory end-stage congestive heart failure: a challenge facing a no-win situation. Nephrol Dial Transplant. 2005; 20 Suppl 7: vii32-6.
24. Hebert MJ, Falardeau M, Pichette V, Houde M, Nolin L, Cardinal J, et al. Continuous ambulatory peritoneal dialysis for patients with severe left ventricular systolic dysfunction and end-stage renal disease. Am J Kidney Dis. 1995; 25: 761-768.
25. Konig P, Geissler D, Lechleitner P, Spielberger M, Dittrich P. Improved management of congestive heart failure. Use of continuous ambulatory peritoneal dialysis. Arch Intern Med. 1987; 147: 1031-1034.
26. Cnossen N, Kooman JP, Konings CJ, van Dantzig JM, van der Sande FM, Leunissen K. Peritoneal dialysis in patients with congestive heart failure. Nephrol Dial Transplant. 2006; 21 Suppl 2: ii63-6.